Tobias Machewitz

5PUBLICATIONS
21CO-AUTHORS
Optical technologyVision scienceMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 11, 2026
SPECTRUM: Early clinical experience from the first global real-world study of aflibercept 8 mg in patients with diabetic macular oedema.

|Jan 30, 2026
SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degeneration.

Clare Bailey, Clemens Lange, Varun Chaudhary

|Jan 16, 2026
Infographic: SPECTRUM: study design of the global real-world study of aflibercept 8 mg in the treatment of neovascular age-related macular degeneration and diabetic macular edema.

Clare Bailey, Clemens Lange, Marion R Munk

|Apr 12, 2025
Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration.

Katja Hatz, Aude Ambresin, Martin Schmid

|Apr 10, 2025
A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES & ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning.

Matthias Gutfleisch, Britta Heimes-Bussmann, Sökmen Aydin

Pageof 1

Frequent Collaborators

3 joint publications

Varun Chaudhary

3 joint publications

Marion R Munk

3 joint publications

Clare Bailey

2 joint publications

Paolo Lanzetta